A course of oral drugs used to treat type 2 diabetes may compose heart failure worse, according to an editorial published online in Heart Wednesday by two Wake Forest University School of Medicine faculty members. “We strongly recommend restrictions in the use of thiazolidinediones (the course...

Cook Medical announced a meaningful milestone for its EVOLUTION® Mechanical Dilator Sheath technology, an innovative new tool designed to remove faulty, ineffective leads in patients with cardiac pacemakers. To term, 200 medical centers in the United States have adopted the breakthrough technology that...

The Endocrine Society has released a new clinical practice guideline for the detection, diagnosis, and treatment of patients with primary aldosteronism. The guidelines seem in the September issue of the Journal of Clinical Endocrinology & Metabolism (JCEM), a publication of The Endocrine Society....

An worldly study, led by the University of Edinburgh, raises concerns that some patients may not be receiving the optimum medical treatment and follow-up care considering doctors are misjudging the risk of a further heart attack. Researchers looked at goods taken from the Global Registry of Coronary...

A team of researchers at West Virginia University has shown that U.S. immigrants from India and Pakistan take on the habits of their adopted country, increasing their risks of prostate cancer among male immigrants and breast cancer among females. “Breast cancer and prostate cancer develop due...

ImClone Systems Incorporated (NASDAQ: IMCL), a global leader in the development and commercialization of novel antibodies to treat cancer, today announced that its disease-directed Phase 2 clinical trial in patients with advanced prostate cancer randomized to treatment with either IMC-A12 or IMC-1121B...

Curis, Inc. (NASDAQ: CRIS), a drug development company focused on developing next generation proprietary targeted medicines for cancer treatment, announced that the first patient has been treated in a Phase I clinical trial of CUDC-101, a first-in-class small molecule drug candidate that has been designed...

According to Millennium Research Group’s (MRG) US Markets for Transcatheter Embolization and Occlusion Devices 2008 report, embolization particle therapies such as radioembolization spheres are increasingly being used to treat liver cancer. Original post by Women’s Health...

Morphotek®, Inc., a subsidiary of Eisai Corporation of North America, announced that it has opened clinical sites in the European Union (EU) as part of the company’s MORAb-009 Phase II study. The study is evaluating MORAb-009, a monoclonal antibody to mesothelin, as a first-line treatment for...

Now that the opening act is by, lets welcome the Paralympians to the field. Michael Phelps should try swimming with his hand behind his back. Or how about wheelchair rugby pictured on the right? We are, of course, excited to be able to see all kinds of assistive devices in direct competition...

Aperio Technologies, Inc., (Aperio), a global leader in digital pathology for the healthcare and life sciences industry, has received clearance from the U.S. Food and Drug Administration (FDA) to market the ER and PR image analysis applications available through its patented ScanScope® slide scanning...